|
1
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu XL, Wen SY, Ai ZH, Wang J, Xu YL and
Teng YC: Screening for characteristic microRNAs between
pre-invasive and invasive stages of cervical cancer. Mol Med Rep.
12:55–62. 2015.PubMed/NCBI
|
|
5
|
Hui A, How C, Ito E and Liu FF: Micro-RNAs
as diagnostic or prognostic markers in human epithelial
malignancies. BMC Cancer. 11:5002011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee HY, Han SS, Rhee H, Park JH, Lee JS,
Oh YM, Choi SS, Shin SH and Kim WJ: Differential expression of
microRNAs and their target genes in non-small-cell lung cancer. Mol
Med Rep. 11:2034–2040. 2015.PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu H and Mo YY: Targeting miR-205 in
breast cancer. Expert Opin Ther Targets. 13:1439–1448. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tran N, McLean T, Zhang X, Zhao CJ,
Thomson JM, O'Brien C and Rose B: MicroRNA expression profiles in
head and neck cancer cell lines. Biochem Biophys Res Commun.
358:12–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lebanony D, Benjamin H, Gilad S, Ezagouri
M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, et
al: Diagnostic assay based on hsa-miR-205 expression distinguishes
squamous from nonsquamous non-small-cell lung carcinoma. J Clin
Oncol. 27:2030–2037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang M, Zhang P, Hu G, Xiao Z, Xu F,
Zhong T, Huang F, Kuang H and Zhang W: Relative expressions of
miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of
non-small cell lung cancer patients. Mol Cell Biochem. 383:67–75.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: MicroRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:(Database issue).
D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43:(Database issue). D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gene Ontology Consortium: Gene ontology
consortium: Going forward. Nucleic Acids Res. 43:(Database issue).
D1049–D1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
20
|
Hedley BD and Chambers AF: Tumor dormancy
and metastasis. Adv Cancer Res. 102:67–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elgamal OA, Park JK, Gusev Y,
Azevedo-Pouly AC, Jiang J, Roopra A and Schmittgen TD: Tumor
suppressive function of mir-205 in breast cancer is linked to HMGB3
regulation. PLoS One. 8:e764022013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sahoo S and Albrecht AA: Ranking of
microRNA target prediction scores by Pareto front analysis. Comput
Biol Chem. 34:284–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Witkos TM, Koscianska E and Krzyzosiak WJ:
Practical aspects of microRNA target prediction. Curr Mol Med.
11:93–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X: miRDB: A microRNA target
prediction and functional annotation database with a wiki
interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hofacker IL: How microRNAs choose their
targets. Nat Genet. 39:1191–1192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mouillet JF, Chu T, Nelson DM, Mishima T
and Sadovsky Y: MiR-205 silences MED1 in hypoxic primary human
trophoblasts. FASEB J. 24:2030–2039. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jullien N, Dieudonné FX, Habel N, Marty C,
Modrowski D, Patino A, Lecanda F, Sévère N and Marie PJ: ErbB3
silencing reduces osteosarcoma cell proliferation and tumor growth
in vivo. Gene. 521:55–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai YH, Tang YP, Zhu HY, Lv L, Chu Y, Zhou
YQ and Huo JR: ZEB2 promotes the metastasis of gastric cancer and
modulates epithelial mesenchymal transition of gastric cancer
cells. Dig Dis Sci. 57:1253–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tung KH, Lin CW, Kuo CC, Li LT, Kuo YH,
Lin CW and Wu HC: CHC promotes tumor growth and angiogenesis
through regulation of HIF-1α and VEGF signaling. Cancer Lett.
331:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yano T, Doi T, Ohtsu A, Boku N, Hashizume
K, Nakanishi M and Ochiai A: Comparison of HER2 gene amplification
assessed by fluorescence in situ hybridization and HER2 protein
expression assessed by immunohistochemistry in gastric cancer.
Oncol Rep. 15:65–71. 2006.PubMed/NCBI
|
|
31
|
Chang ZG, Wei JM, Qin CF, Hao K, Tian XD,
Xie K, Xie XH and Yang YM: Suppression of the epidermal growth
factor receptor inhibits epithelial-mesenchymal transition in human
pancreatic cancer PANC-1 cells. Dig Dis Sci. 57:1181–1189. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rhodes LV, Tate CR, Segar HC, Burks HE,
Phamduy TB, Hoang V, Elliott S, Gilliam D, Pounder FN, Anbalagan M,
et al: Suppression of triple-negative breast cancer metastasis by
pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT
master regulators. Breast Cancer Res Treat. 145:593–604. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gheldof A and Berx G: Cadherins and
epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci.
116:317–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miura N, Yano T, Shoji F, Kawano D,
Takenaka T, Ito K, Morodomi Y, Yoshino I and Maehara Y:
Clinicopathological significance of Sip1-associated epithelial
mesenchymal transition in non-small cell lung cancer progression.
Anticancer Res. 29:4099–4106. 2009.PubMed/NCBI
|
|
35
|
Elloul S, Elstrand MB, Nesland JM, Tropé
CG, Kvalheim G, Goldberg I, Reich R and Davidson B: Snail, Slug,
and Smad-interacting protein 1 as novel parameters of disease
aggressiveness in metastatic ovarian and breast carcinoma. Cancer.
103:1631–1643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker K: Differential expression of
the epithelial-mesenchymal transition regulators snail, SIP1, and
twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou C, Liu J, Tang Y, Zhu G, Zheng M,
Jiang J, Yang J and Liang X: Coexpression of hypoxia-inducible
factor-2α, TWIST2, and SIP1 may correlate with invasion and
metastasis of salivary adenoid cystic carcinoma. J Oral Pathol Med.
41:424–431. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sakamoto K, Imanishi Y, Tomita T, Shimoda
M, Kameyama K, Shibata K, Sakai N, Ozawa H, Shigetomi S, Fujii R,
et al: Overexpression of SIP1 and downregulation of E-cadherin
predict delayed neck metastasis in stage I/II oral tongue squamous
cell carcinoma after partial glossectomy. Ann Surg Oncol.
19:612–619. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Oztas E, Avci ME, Ozcan A, Sayan AE,
Tulchinsky E and Yagci T: Novel monoclonal antibodies detect
Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells
from multiple tumor tissue arrays. Exp Mol Pathol. 89:182–189.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xia M, Hu M, Wang J, Xu Y, Chen X, Ma Y
and Su L: Identification of the role of Smad interacting protein 1
(SIP1) in glioma. J Neurooncol. 97:225–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger
B, Guo J and Xu X: Loss of microRNA-205 expression is associated
with melanoma progression. Lab Invest. 92:1084–1096. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dodge GR, Kovalszky I, McBride OW, Yi HF,
Chu ML, Saitta B, Stokes DG and Iozzo RV: Human clathrin heavy
chain (CLTC): Partial molecular cloning, expression, and mapping of
the gene to human chromosome 17q11-qter. Genomics. 11:174–178.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Humphries AC, Dodding MP, Barry DJ,
Collinson LM, Durkin CH and Way M: Clathrin potentiates
vaccinia-induced actin polymerization to facilitate viral spread.
Cell Host Microbe. 12:346–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
De Paepe P, Baens M, van Krieken H,
Verhasselt B, Stul M, Simons A, Poppe B, Laureys G, Brons P,
Vandenberghe P, et al: ALK activation by the CLTC-ALK fusion is a
recurrent event in large B-cell lymphoma. Blood. 102:2638–2641.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu Y, Qi C, Jain S, Rao MS and Reddy JK:
Isolation and characterization of PBP, a protein that interacts
with peroxisome proliferator-activated receptor. J Biol Chem.
272:25500–25506. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Drané P, Barel M, Balbo M and Frade R:
Identification of RB18A, a 205 kDa new p53 regulatory protein which
shares antigenic and functional properties with p53. Oncogene.
15:3013–3024. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Crawford SE, Qi C, Misra P, Stellmach V,
Rao MS, Engel JD, Zhu Y and Reddy JK: Defects of the heart, eye,
and megakaryocytes in peroxisome proliferator activator
receptor-binding protein (PBP) null embryos implicate GATA family
of transcription factors. J Biol Chem. 277:3585–3592. 2002.
View Article : Google Scholar : PubMed/NCBI
|
